Your session is about to expire
← Back to Search
Botox for Migraine
Study Summary
This trial is investigating whether Botox could be an effective treatment for post-stroke headaches, which are similar to migraines.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- We will include headaches that started within 72 hours before and 7 days after a stroke. This includes headaches that may indicate a stroke is about to happen.I am not taking CGRP inhibitors during the study.I do not have allergies to Botox or any neuromuscular illnesses.Having headaches from overusing medication won't stop me from joining.I do not have chronic migraines or specific post-stroke pain conditions.My headache from a previous clot in my brain has lasted more than 6 months, and scans show the clot issue is resolved.I have persistent headaches after surgery, even without a clear stroke sign, but with a history of vascular issues.I started having headaches around the time of my stroke.Patients with persistent headaches after a dissection may be included in the study, even if there is no identified ischemic lesion, as long as they have a history of stabilized vascular injury associated with the syndrome.My headache from CVST has lasted over 6 months and scans show no current structural issues.Having headaches from too much medication does not disqualify me.I am an adult with long-lasting headaches after a stroke or similar condition, lasting 3 months or more.I do not have any ongoing serious illnesses like infections or autoimmune diseases.
- Group 1: Control
- Group 2: Treatment Arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What medical symptomology is Botox 200 UNT Injection typically used to alleviate?
"Botox 200 UNT Injection can be a viable solution for treating urinary incontinence, but it also has applications in the management of numerous ailments including spinal cord issues, botulism, and overactive bladder syndrome (OABs)."
Does the FDA sanction Botox 200 UNT Injection?
"With the limited data available on Botox 200 UNT Injection, it has been assigned a safety rating of 1. This Phase 1 trial is still in its early stages and does not have significant evidence for either efficacy or safety."
Are there any historical accounts of employing Botox 200 UNT Injection for research purposes?
"Currently, there are a total of 61 clinical trials for Botox 200 UNT Injection taking place. Of these, 20 have advanced to Phase 3 testing. Most studies are being conducted in Farmington Hills, Michigan; however, global participation and data collection is occurring at 754 sites worldwide."
What are the principal aims of this clinical experiment?
"This clinical trial will evaluate the efficacy of a treatment over a two year period, with the primary outcome being change in number of moderate to severe migraine days. Secondary outcomes include headache intensity measured on an 11-point visual rating scale (VRS), cumulative hours per 28 days of moderate/severe pain, and conversion to episodic migraine based upon fewer than 14 migraine or headache days per four weeks for 12 consecutive weeks."
Are there any opportunities for patients to join this clinical trial?
"This trial is no longer actively recruiting patients. It was posted on December 1st 2022 and last updated on July 11th 2022. Fortunately, there are 1453 clinical trials for hemorrhagic stroke still seeking enrolment as well as 61 studies involving Botox 200 UNT Injection that remain open to participants."
How many participants have currently been recruited for this experiment?
"This research project has concluded its recruitment process, with the initial post on December 1st 2022 and last edit being made July 11th 2022. If you are still interested in partaking in a trial of this nature, there are currently 1453 clinical trials involving hemorrhagic stroke and 61 studies for Botox 200 UNT Injection recruiting patients."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
What site did they apply to?
Why did patients apply to this trial?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger